reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

{"id": "ocd-bill/0e6db9e8-e382-4100-b698-bf00e9cd3edf", "session": "2026", "jurisdiction": {"id": "ocd-jurisdiction/country:us/state:sd/government", "name": "South Dakota", "classification": "state"}, "from_organization": {"id": "ocd-organization/2432bd5a-3c3f-4784-b1f5-c6134171162b", "name": "House", "classification": "lower"}, "identifier": "HB 1099", "title": "reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.", "classification": ["bill"], "subject": ["Controlled Substances", "Public Health and Safety"], "extras": {}, "created_at": "2026-01-20T20:19:50.033630+00:00", "updated_at": "2026-04-24T07:08:35.225534+00:00", "openstates_url": "https://openstates.org/sd/bills/2026/HB1099/", "first_action_date": "2026-01-21", "latest_action_date": "2026-03-10", "latest_action_description": "Signed by the Governor on 2026-03-10 H.J. 547", "latest_passage_date": "2026-03-04"}